Blog: Specialty subsectors such as oncology are attracting the greatest M&A interest from big pharma

Jun 2nd 2017 Author:

Michael Jewell

View Profile

In his latest ASCO-themed expert view piece, Michael Jewell, healthcare partner at Cavendish Corporate Finance, discusses why the oncology sector is seeing increased M&A activity and offers advice to buyers and sellers on how to maximize opportunities in the market and complete deals on the most favorable terms.

Read full article in Pharma Letter here